Complete atrioventricular block after TAVI: When is pacemaker implantation safe?

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 7, 2013, Pages 898-903

  Schwerg, Marius ^a   Baldenhofer, Gerd ^a   Dreger, Henryk ^a   Bondke, Hansjürgen ^a   Stangl, Karl ^a   Laule, Michael ^a   Melzer, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

anticoagulation; antiplatelet therapy; pacemaker; TAVI

Indexed keywords

ANTITHROMBOCYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; FEMALE; HEMATOMA; HEMATOTHORAX; HUMAN; IMPLANTED HEART PACEMAKER; MALE; PERFORATION; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SURGICAL DRAINAGE; SURGICAL INFECTION; TRANSCATHETER AORTIC VALVE IMPLANTATION;

ANTICOAGULATION; ANTIPLATELET THERAPY; PACEMAKER; TAVI;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; COMORBIDITY; FEMALE; GERMANY; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84879688157     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12150     Document Type: Article

References (23)

1. Figulla L, Neumann A, Figulla HR, Kahlert P, Erbel R, Neumann T,. Transcatheter aortic valve implantation: Evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol 2011; 100: 265-276.
2. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: Incidence and contributing factors (the UK CoreValve Collaborative). Circulation 2011; 123: 951-960.
3. Bagur R, Rodes-Cabau J, Gurvitch R, Dumont E, Velianou JL, Manazzoni J, Toggweiler S, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv 2012; 5: 540-551.
4. Liang M, Devlin G, Pasupati S,. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves. J Invasive Cardiol 2012; 24: 173-176.
5. Urena M, Mok M, Serra V, Dumont E, Nombela-Franco L, Delarochelliere R, Doyle D, et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol 2012; 60: 1743-1752.
6. Schroeter T, Linke A, Haensig M, Merk DR, Borger MA, Mohr FW, Schuler G,. Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace 2012; 14: 1759-1763.
7. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P, Pilgrim T, et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 2012; 60: 493-501.
8. Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, Cheng J, et al. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J 2011; 32: 2067-2074.
9. Fraccaro C, Al-Lamee R, Tarantini G, Maisano F, Napodano M, Montorfano M, Frigo AC, et al. Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: Immediate and mid-term results, a multicenter study. Circ Cardiovasc Interv 2012; 5: 253-260.
10. McGee DC, Gould MK,. Preventing complications of central venous catheterization. N Engl J Med 2003; 348: 1123-1133.
11. Mahapatra S, Bybee KA, Bunch TJ, Espinosa RE, Sinak LJ, McGoon MD, Hayes DL,. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm 2005; 2: 907-911.
12. Wiegand UK, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, Bode F,. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: Influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 2004; 126: 1177-1186.
13. Thal S, Moukabary T, Boyella R, Shanmugasundaram M, Pierce MK, Thai H, Goldman S,. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation. Pacing Clin Electrophysiol 2010; 33: 385-388.
14. Chauhan A, Grace AA, Newell SA, Stone DL, Shapiro LM, Schofield PM, Petch MC,. Early complications after dual chamber versus single chamber pacemaker implantation. Pacing Clin Electrophysiol 1994; 17 (11 Pt 2): 2012-2015.
15. Dreger H, Grohmann A, Bondke H, Gast B, Baumann G, Melzer C,. Is antiarrhythmia device implantation safe under dual antiplatelet therapy ? Pacing Clin Electrophysiol 2010; 33: 394-399.
16. Healey JS, Toff WD, Lamas GA, Andersen HR, Thorpe KE, Ellenbogen KA, Lee KL, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: Meta-analysis of randomized trials, using individual patient data. Circulation 2006; 114: 11-17.
17. Armaganijan LV, Toff WD, Nielsen JC, Andersen HR, Connolly SJ, Ellenbogen KA, Healey JS,. Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials. Pacing Clin Electrophysiol 2012; 35: 131-134.
18. Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE,. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol 1999; 22: 711-720.
19. Li HK, Chen FC, Rea RF, Asirvatham SJ, Powell BD, Friedman PA, Shen WK, et al. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure. Pacing Clin Electrophysiol 2011; 34: 868-874.
20. Michaud GF, Pelosi F Jr., Noble MD, Knight BP, Morady F, Strickberger SA,. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. J Am Coll Cardiol 2000; 35: 1915-1918.
21. Robinson M, Healey JS, Eikelboom J, Schulman S, Morillo CA, Nair GM, Baranchuk A, et al. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 2009; 32: 378-382.
22. Goldstein DJ, Losquadro W, Spotnitz HM,. Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 1998; 21: 1730-1734.
23. al-Khadra AS,. Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol 2003; 26 (1 Pt 2): 511-514.